MassMutual Private Wealth & Trust’s Indaptus Therapeutics INDP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$30	–	2202
2024 Q2	$30	Buy	+1	New	+$66	﹤0.01%	2120

Other funds holding INDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

MassMutual Private Wealth & Trust's INDP Position: Q3 2024 in Review

MassMutual Private Wealth & Trust sold out of Indaptus Therapeutics (INDP) in Q3 2024, closing a stake of 1 share — an estimated $30 sold.

MassMutual Private Wealth & Trust first reported a position in INDP in Q2 2024 and held it in 1 quarter. The position peaked at $30 in Q2 2024. 16 funds tracked by Wall St. Rank hold INDP as of Q3 2024.

MassMutual Private Wealth & Trust reported no remaining Indaptus Therapeutics position as of Q3 2024 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 1 Indaptus Therapeutics share in Q3 2024, an estimated $30.
MassMutual Private Wealth & Trust first reported a position in Indaptus Therapeutics in Q2 2024 and held it in 1 quarter.
MassMutual Private Wealth & Trust's Indaptus Therapeutics position peaked at $30 in Q2 2024.
16 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2024.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2024, filed 2 Oct 2024.